Compare RR & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RR | CTKB |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 614.9M | 541.1M |
| IPO Year | 2023 | 2021 |
| Metric | RR | CTKB |
|---|---|---|
| Price | $1.50 | $4.41 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $4.00 | ★ $5.63 |
| AVG Volume (30 Days) | ★ 7.2M | 853.5K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,045,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $75.68 | $5.42 |
| Revenue Next Year | $78.28 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.99 | 17.67 |
| 52 Week Low | $1.53 | $3.28 |
| 52 Week High | $7.43 | $6.18 |
| Indicator | RR | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 28.90 | 46.03 |
| Support Level | N/A | $4.31 |
| Resistance Level | $2.21 | $4.49 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 1.32 | 11.34 |
Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.